Segmed, Inc. collaborates with life sciences, healthcare, and technology leaders to streamline access to diverse, high-quality medical imaging studies for biopharmaceutical R&D, AI development, and medical device innovation. With a global network of healthcare partners across five continents, Segmed provides researchers with over 100 million de-identified, standardized imaging datasets through its proprietary platform — empowering safer, faster, and more equitable healthcare advancements. For more information, visit www.segmed.ai or follow us on LinkedIn @segmed-ai.